EE352 A Budget Impact Analysis of Cladribine in England and Wales for Patients With Highly Active Relapsing-Remitting Multiple Sclerosis (HA-RRMS)
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.618
https://www.valueinhealthjournal.com/article/S1098-3015(23)03748-8/fulltext
Title :
EE352 A Budget Impact Analysis of Cladribine in England and Wales for Patients With Highly Active Relapsing-Remitting Multiple Sclerosis (HA-RRMS)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03748-8&doi=10.1016/j.jval.2023.09.618
First page :
Section Title :
Open access? :
No
Section Order :
10107